Following Recalls, Digitek Manufacturer to Remain Shut Down
The U.S. Department of Justice and the FDA have taken steps to continue barring Actavis Totowa from manufacturing and distributing generic drugs. The actions were taken following a series of serious manufacturing problems which resulted in a nationwide Digitek recall earlier this year when double strength tablets were produced, and a subsequent recall that involved potential issues with over 65 different generic drugs.
On November 14, 2008, the Justice Department announced that the United States government has filed a lawsuit seeking a permanent injunction against Actavis Totowa LLC, their parent company Actavis Inc. and two of the company’s executives, barring them from manufacturing and distributing generic drugs until they can demonstrate their ability to comply with the Good Manufacturing Practice requirements of the Federal Food, Drug and Cosmetic Act.
Actavis Totowa has received a number of warnings for distributing adulterated and misbranding drugs, and the FDA has found numerous, recurring violations of Good Manufacturing Practices during their inspections of the company’s facilities.
Did You Know?
Millions of Philips CPAP Machines Recalled
Philips DreamStation, CPAP and BiPAP machines sold in recent years may pose a risk of cancer, lung damage and other injuries.Learn More
In April 2008, manufacturing problems at Actavis Totowa’s plant in New Jersey resulted in a recall of Digitek tablets, a generic form of digoxin , which were twice as thick as they were supposed to be and contained up to twice the appropriate active ingredient.
As a result of the Digitek problems, hundreds of users have claimed that they suffered serious injury, such as renal impairment, cardiac arrhythmias and death, caused by digoxin overdose. A number of these users have filed Digitek lawsuits against Actavis and their distributors, and additional lawsuits are being filed every week.
On August 1, 2008, Actavis Totowa was also forced to recall over 65 different generic drugs due to non-compliance with Good Manufacturing Practice requirements at the same New Jersey plant. Although Actavis has claimed that these tablets do not pose any health risks, the FDA required them to recall millions of generic painkillers, antidepressants, hypertension, blood pressure and diet drugs.
The Department of Justice filed for the permanent injunction after Actavis Totowa recently informed the FDA that they wanted to restart manufacturing of drug products. However, the FDA still does not believe that they have demonstrated that they can follow the Good Manufacturing Practice requirements.
Actavis Totowa has indicated that they view the action as one step in a long process of regulation and they claim that they remain fully committed to collaborating with the FDA to ensure that their facilities and products comply with Federal regulations.
BruceNovember 18, 2008 at 3:56 pm
Well the Department of Justice Can not shut down this company without shutting down KV Pharmicies because KV has had five recalls and no inspections and has killed more people that Actavis. Why pick on these guys? Is K-V and Ethex favoriate children or big contributors to the campaign? NO NO NO, Is it because a Lawyer named Lawrence Brody of the Bryan Cave Law Firm ownes almost five million share[Show More]Well the Department of Justice Can not shut down this company without shutting down KV Pharmicies because KV has had five recalls and no inspections and has killed more people that Actavis. Why pick on these guys? Is K-V and Ethex favoriate children or big contributors to the campaign? NO NO NO, Is it because a Lawyer named Lawrence Brody of the Bryan Cave Law Firm ownes almost five million shares? Come on Department of Justice, Do not shut them down.
"*" indicates required fields
More Top Stories
Defendants want to divide the discovery process to focus on the causal links between hair relaxers and cancer.
The FDA has announced it has received 106,000 medical device reports linked to recalled Philips CPAP devices, including nearly 400 deaths.
The U.S. JPML has consolidated all Tepezza lawsuits over hearing loss before one Northern Illinois federal judge for coordinated pretrial proceedings.